CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4/A Open-market buy 10% owner bought 272,727 shares at $11.00 ($2,999,997)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 8,100 shares at an average $7.62 ($61,723)
- 4 Open-market sale 10% owner sold 5,000 shares at an average $7.51 ($37,536)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 8,300 shares at an average $7.72 ($64,040)
- 4 Open-market sale 10% owner sold 15,900 shares at an average $7.76 ($123,452)
- 4 Open-market sale 10% owner sold 1,200 shares at $7.54 ($9,048)
- 4 Open-market sale 10% owner sold 2,000 shares at an average $7.75 ($15,500)
Page 13 of 15 · 287 filings